The Weinberg Group

The Weinberg Group, a ProPharma Group company, is the global leader in regulatory and compliance services, with headquarters in Washington, D.C. For over 35 years, we have provided biotech, medical device, and pharmaceutical consulting services to companies of every size on every continent, supplying them with viable and efficient drug development pathways and compliance solutions. The Weinberg Group was acquired by ProPharma Group on January 25, 2019. By joining forces, we expand our current service portfolio of pre-approval/pre-clinical regulatory service solutions to also now include post-approval regulatory services, establishing an end-to-end global solution for our clients. Our service footprint now...

Pharmaceuticals,biologics,biotech,medical devices,diagnostics,ivds,gcp compliance,clinical pharmacology,consulting,glp compliance,gmp compliance,quality assurance/control,regulatory affairs/regulatory strategy,and regulatory document preparation

The weinberg group operates in the Pharmaceutical manufacturing industry.

The weinberg group's revenue is 11m - 100m

The weinberg group has 11 - 50 employees.